Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.

Hypercalcaemia is an important cause of morbidity in malignant disease. We studied the efficacy and safety of intravenous ibandronate (a new, potent bisphosphonate) in a multicentre study of 147 patients with severe cancer-associated hypercalcaemia which had been resistant to treatment with rehydrat...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ralston, S. H., Thiébaud, D., Herrmann, Z., Steinhauer, E. U., Thürlimann, B., Walls, J., Lichinitser, M. R., Rizzoll, R., Hagberg, H., Huss, H. J., Tubiana-Hulin, M., Body, J. J.
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group|1 1997
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2063262/
https://ncbi.nlm.nih.gov/pubmed/9010041
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы